The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

SUPN FINANCIAL STATEMENTS

Supernus Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

SUPNSupernus Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue830.4 M $Gross Profit731.4 M $ · 88%Operating Income-111.8 M $ · -13%Pre-tax Income-123.5 M $ · -15%Net Income to Owners-109.9 M $ · -13%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue830.4 M $+24.9%
Gross Profit731.4 M $+24.2%
Operating Income-111.8 M $-274.3%
EBITDA-15.9 M $-109.6%
Net Income to Owners-109.9 M $-270.4%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.4 B
  • Equity1 B $72%
  • Current Liabilities347.4 M $24%
  • Long-term Liabilities49.5 M $3%

Key Figures

YoY change
Total Assets1.4 B $+3.3%
Total Liabilities396.9 M $+24.6%
Total Equity1 B $-3.1%
Cash & ST Investments372.1 M $-28.8%
Total Debt40.2 M $+26.4%
Net Debt-139.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
020 M19.9 M $Operating-14.7 M $Investing31.5 M $Financing36.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow19.9 M $-89.4%
Capital Expenditures1.1 M $-5.9%
Free Cash Flow18.8 M $-89.9%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SUPN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.